Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving ...

Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

In paediatrics, “more trials have been done over the last ten years, but we have struggled with transparency and clarity, and sometimes with the quality because they are not always asking the ...

Much uncertainty remains in the evidence base for child and adolescent health. Not only is the quality of clinical trials ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Consensus Offers Clinicians Structured Guidance on When and How to Reassess, Taper, or Discontinue Psychotropic ...

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use ...

Clinical trials are not just about testing medicines; they are about building the future of healthcare There is a dire need for awareness about clinical research in India to deliver innovative safe an ...

In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...

Even when promising clinical trials exist, and the FDA allows expanded access, rare disease patients like my granddaughter ...